Empower Pharmacy
Buying intent
66 tracked signals | Top 15 topics are below | HR and Operations are carrying most of it.
Attention by team
LinkedIn activity, by teamWhere Empower Pharmacy's own people are actually spending their attention, by team, by topic. Bands run Low to High against the busiest pairing on this page, and each cell also shows how much of that team's own activity it represents.
Topics being researched
30-day windowEvery tracked topic, ranked by volume, not by our guess at what matters. Confidence is the classifier's own certainty that a signal belongs where we've filed it.
11d ago
22d ago
22d ago
10d ago
20d ago
20d ago
30d ago
17d ago
24d ago
17d ago
30d ago
25d ago
17d ago
25d ago
21d ago
Need intent for a specific topic or industry?
We track the full taxonomy across every account in the graph — including themes not shown on this page.
Who's active at Empower Pharmacy
verified title on fileTitles, seniority and topic straight from each person's own activity, with a LinkedIn link so you can check any of them yourself.
See everyone, not just the first 10
20 people across every department at Empower Pharmacy, plus a LinkedIn profile link for each.
Primary products / business lines
LinkedIn company profileEmpower Pharmacy and Empower Pharma are transforming the landscape of compounding pharmaceuticals by delivering personalized, high-quality medication solutions at scale. As a national leader in innovation, we specialize in meeting unique patient needs with tailored medications unavailable through traditional commercial options. Whether it's customizing dosages, eliminating allergens, or creating c
New capability sought
Employee posts (LinkedIn)Financial Services; Job Market; Society for Human Resource Management (SHRM); Student Recruitment; Talent Acquisition
Top accounts researching Empower Pharmacy
names withheld on the public pageThese are companies whose own people brought up Empower Pharmacy unprompted, not accounts we guessed might be interested. We can't yet tell an implementation partner from a genuine buyer here, names unlock along with the buyer profile below.
151,426 companies · 839,012 people are researching Artificial Intelligence
Empower Pharmacy's own team shows 6 signals on this topic. No one outside Empower Pharmacy has been seen researching the company by name yet — so this is the market it sits in, not a list of its buyers.
- People Analytics1,092 cos · 3,479 people
- Human Resources -> Employee Services3,686 cos · 14,366 people
Buyer profile
company size · seniorityCompany size and how senior the people involved are, the two things that decide whether this is a real deal. Competitor overlap isn't computed yet for this account.
Buying committee functions
Employee job titles (LinkedIn)HR / Talent — 5 people; Operations — 4 people; Leadership — 2 people; Sales — 1 person; Engineering — 1 person
What's been said
public posts by Empower Pharmacy's teamNo public post naming Empower Pharmacy has surfaced in the past year, so this is what Empower Pharmacy's own team is posting about publicly — their topics, in their words.
What are the biggest legal and operational challenges currently reshaping the specialty pharmacy industry? Following conversations with stakeholders across the healthcare and pharmacy landscape at Asembia's AXS26 Summit, there were four major trends impacting specialty pharmacies, infusion providers, health systems, and healthcare investors — including insurer claim denials, PBM network barriers, 340B and IRA compliance challenges, and the growing role of artificial intelligence in pharmacy operations. Read more.
May 2026Something tells me the recruitment agency market is insanely oversaturated. Every time I post a job, I get more agency recruiters trying to connect with me then applicants in my first week of the job going live. Today alone, I had 34 recruiters try to connect with me from the US, UK, India, Dubai, South Africa, and everywhere in between. At this point it feels less like recruiting and more like an international spam contest. And let’s be honest, if your LinkedIn says you’re “based in New Jersey,” but your entire background says you went to school somewhere overseas, and your company’s “office” is a storage unit in Wisconsin or a random apartment, I’m probably not taking you seriously. The fake-location outsourcing thing isn’t exactly subtle anymore. The reality is most established companies don’t really need agencies anymore, which is why so many agencies target startups, Series A/B/C companies, fintechs, and small biotechs that are still figuring out hiring and are easier to sell recruiting services to and also can sell 30% total comp terms and they don't realize they are being ripped off when there is someone out there who will do 18%-20% with better guarantees. Meanwhile, a huge percentage of agency outreach is just mass messaging, recycled resumes, and people recruiting for industries they clearly don’t understand. The market is bloated, noisy, and full of nonsense. Then agencies wonder why hiring managers and internal recruiters are skeptical of every cold message they get. Don't get me wrong there are some BOMB agency recruiters and agencies, but they are far few in between.
May 2026Nobody talks about the air. This is what pharmaceutical-grade air looks like before it reaches a cleanroom. Massive HVAC units. Multi-stage filtration. Redundant systems. Controlled pressure differentials designed so that if a door opens, air flows out. Never in. The air in our classified manufacturing areas is monitored. Particle counts per cubic meter. Temperature. Humidity. Pressure. Every shift. Every minute of every day. Every medication we make is made in that air. A painted room with a HEPA filter is not a classified manufacturing environment. The difference between the two is the difference between pharmaceutical-grade and theater. That distinction matters when a patient injects what you made. The air never makes headlines. It makes safe medicine. We have been building the right environment for a long time. Not because it's required. Because it's what the work demands.
May 2026PBM audits and investigations targeting prescription solicitation practices are increasing across the pharmacy industry. Read more about why prescription solicitation raises claim validity and compliance concerns, how PBMs are evaluating these arrangements, and the risks pharmacies should be assessing now.
May 2026For two decades, women were told the medication that could help them was dangerous. The prescriptions dropped. The fear took hold. A black box warning on hormone replacement therapy did exactly what it was designed to do. It stopped a generation of women from accessing a therapy that, for many of them, would have given back their lives. But not every prescriber accepted that verdict. There were doctors who read the actual trial. Doctors who saw the women in front of them suffering. Doctors who understood the women in the 2002 Women's Health Initiative did not represent the women sitting in their exam rooms. Those prescribers needed a partner. Compounding pharmacies were that partner. When the commercial market retreated, compounding stayed. Estradiol creams in strengths the commercial market did not offer. Bioidentical progesterone capsules dosed for the individual patient. Topical bases for women who could not tolerate oral therapy. Specific ratios of estradiol and estriol no major manufacturer would ever make. Combination formulations that respected the way a woman's body actually responds. Compounding does not exist to fill gaps. Compounding exists because the human body does not come in standard doses. I have watched what this work means to women in their forties, fifties, and sixties. The relief of being heard. The return of sleep, of focus, of the version of themselves they thought they had lost. Behind every customized prescription is a clinician who refused to give up, and a patient who refused to be told her suffering was acceptable. The labels have changed. The mission has not. Compounding was the bridge for these women when the system failed them. It will be the foundation of personalized medicine long after the next labeling change is forgotten. This is what we built. This is who we serve. What does medicine look like when it is finally built around the patient instead of the average?
May 2026Regulatory scrutiny across the healthcare industry continues to intensify, and the margin for compliance error is shrinking. The April edition of the Frier Levitt Healthcare Newsletter highlights the latest legal developments and enforcement activity impacting providers, pharmacies, and healthcare organizations nationwide. From evolving False Claims Act standards and Medicare audit trends to telehealth risks, DEA enforcement, and new state-level regulatory changes, this edition highlights the issues shaping compliance and operations in 2026. Stay informed on what matters most, including emerging risks, regulatory shifts, and real-world outcomes that can directly impact your organization. Read the full newsletter.
May 2026